Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/06/21
End: 02/14/22
Due: 02/14/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pertussis Acellular Vaccine Adjuvanted With TQL1055 | NCT04793620 | Adjuvance Technologies, Inc. | user2@example.com | None | 2021-04-06 | 2022-02-14 | 2023-02-14 | - | - | 2025-07-14 |